Carisoprodol

Musculoskeletal Diseases, Acute Pain, Acute Coryza

Treatment

5 FDA approvals

4 Active Studies for Carisoprodol

What is Carisoprodol

Carisoprodol

The Generic name of this drug

Treatment Summary

Carisoprodol is a muscle relaxant prescribed to relieve pain in muscles and bones. It is usually taken as a pill, but can also be combined with aspirin or codeine. In 2012, it was classified as a Schedule IV drug in some US states because it was being abused at high rates, even though it has a low potential for abuse and dependence.

Soma

is the brand name

image of different drug pills on a surface

Carisoprodol Overview & Background

Brand Name

Generic Name

First FDA Approval

How many FDA approvals?

Soma

Carisoprodol

1959

193

Approved as Treatment by the FDA

Carisoprodol, also called Soma, is approved by the FDA for 5 uses which include Musculoskeletal Disorders and Pain, Acute .

Musculoskeletal Disorders

Helps manage Musculoskeletal Disorders

Pain, Acute

Helps manage Pain, Acute

Musculoskeletal Diseases

Helps manage Musculoskeletal Disorders

Acute Coryza

Used to treat acute Discomfort in combination with Acetylsalicylic acid

Acute Pain

Helps manage Pain, Acute

Effectiveness

How Carisoprodol Affects Patients

Carisoprodol is a muscle relaxant that works by targeting the central nervous system (CNS). It helps to relieve the pain caused by muscle spasms. A breakdown product of carisoprodol, meprobamate, has calming and sleep-inducing effects. Clinical studies have shown that this drug can impair how a person performs on mental and physical tests.

How Carisoprodol works in the body

The exact way carisoprodol works to reduce muscle pain is not known. Animal studies suggest that it changes the activity between neurons in the spinal cord and the brain. It is also thought to have potential for abuse because it can change the way a certain type of brain receptor works. This alters the flow of neurotransmitters and can have a calming effect.

When to interrupt dosage

The recommended measure of Carisoprodol is based on the diagnosed state, including Acute Pain, Acute Coryza and Musculoskeletal Diseases. The quantity of dosage is contingent upon the method of delivery (e.g. Tablet, film coated - Oral or Oral) stated in the table below.

Condition

Dosage

Administration

Acute Coryza

, 350.0 mg, 250.0 mg, 200.0 mg

, Oral, Tablet - Oral, Tablet, Kit, Tablet, film coated, Tablet, film coated - Oral

Musculoskeletal Diseases

, 350.0 mg, 250.0 mg, 200.0 mg

, Oral, Tablet - Oral, Tablet, Kit, Tablet, film coated, Tablet, film coated - Oral

Acute Pain

, 350.0 mg, 250.0 mg, 200.0 mg

, Oral, Tablet - Oral, Tablet, Kit, Tablet, film coated, Tablet, film coated - Oral

Warnings

Carisoprodol Contraindications

Condition

Risk Level

Notes

Acute Coryza

Do Not Combine

Disorders of Porphyrin Metabolism

Do Not Combine

Severe Hypersensitivity Reactions

Do Not Combine

Carisoprodol may interact with Pulse Frequency

There are 20 known major drug interactions with Carisoprodol.

Common Carisoprodol Drug Interactions

Drug Name

Risk Level

Description

Azelastine

Major

Carisoprodol may increase the central nervous system depressant (CNS depressant) activities of Azelastine.

Ethanol

Major

Carisoprodol may increase the central nervous system depressant (CNS depressant) activities of Ethanol.

Oliceridine

Major

The risk or severity of hypotension, sedation, death, somnolence, and respiratory depression can be increased when Carisoprodol is combined with Oliceridine.

Thalidomide

Major

Carisoprodol may increase the central nervous system depressant (CNS depressant) activities of Thalidomide.

(R)-warfarin

Moderate

The metabolism of (R)-warfarin can be decreased when combined with Carisoprodol.

Carisoprodol Toxicity & Overdose Risk

The toxic dose of carisoprodol for rats when given intravenously or intraperitoneally is 450 mg/kg and 1,320 mg/kg when taken orally. In mice, these numbers are 165 mg/kg, 980 mg/kg, and 2,340 mg/kg respectively. Overdosing on carisoprodol can lead to a coma, shock, breathing problems, seizures, and death in extreme cases. Other symptoms may include dizziness, blurred vision, fast heartbeat, low blood pressure, confusion, hallucinations, and muscle stiffness. Alcohol or other drugs that depress the central nervous system can increase the effects

image of a doctor in a lab doing drug, clinical research

Carisoprodol Novel Uses: Which Conditions Have a Clinical Trial Featuring Carisoprodol?

23 active clinical trials are investigating the potential of Carisoprodol in providing relief from Acute Pain, Acute Coryza and Musculoskeletal Diseases.

Condition

Clinical Trials

Trial Phases

Musculoskeletal Diseases

2 Actively Recruiting

Not Applicable, Phase 2, Phase 3

Acute Coryza

0 Actively Recruiting

Acute Pain

1 Actively Recruiting

Not Applicable

Carisoprodol Reviews: What are patients saying about Carisoprodol?

5

Patient Review

11/20/2015

Carisoprodol for Muscle Spasm

I've used this medication for about two decades to manage my MS-induced muscle spasms, and it's been incredibly effective. I have tried other muscle relaxants in the past, but none of them compare to this one. That said, it is difficult to wean yourself off of this medication after long-term use; you have to do it gradually.

5

Patient Review

12/28/2015

Carisoprodol for Muscle Spasm

I've been taking this medication for a decade and it's really helped me. I have severe lower back and neck pain, and after multiple surgeries (both fused spine segments and plates/pins), this is the only muscle relaxer that offers me consistent relief.

5

Patient Review

11/27/2015

Carisoprodol for Muscle Spasm

Carisoprodol was much more effective than Diazapam at relieving my muscle spasms without making me feel loopy.

5

Patient Review

8/31/2016

Carisoprodol for Muscle Spasm

I've been taking Soma for chronic pain that I've had for 16 years now. It's the only thing that helps.

5

Patient Review

5/7/2016

Carisoprodol for Muscle Spasm

This muscle relaxant is the only one that has helped me with my severe spasms. It's getting harder to find a physician who will prescribe it though, which is concerning.

5

Patient Review

10/17/2018

Carisoprodol for Muscle Spasm

I saw the best results when I took this medication as prescribed and with food.

5

Patient Review

3/7/2015

Carisoprodol for Muscle Spasm

This treatment is amazing! I can't believe how well it worked for me.

4.7

Patient Review

12/31/2014

Carisoprodol for Muscle Spasm

2

Patient Review

10/6/2022

Carisoprodol for Muscle Spasm

Do not drink alcohol or smoke cannabis while on this medication. I had one margarita and two puffs of a joint, and it almost killed me. I started to fade out while driving, and luckily was able to pull over before anything bad happened. My wife called 911 and was crying when they arrived because she thought I had died. So please, heed the warnings on the label and don't mix this drug with other substances!

1.7

Patient Review

1/22/2016

Carisoprodol for Muscle Spasm

I was only recently switched to this medication, but it seems to be working better than the last one. The downside is that it makes me sleepy very quickly, so I can only take it at night.

1.3

Patient Review

2/19/2016

Carisoprodol for Muscle Spasm

I have taken soma for 15 years and it has provided me a lot of relief. However, I got a refill that was CL 022 and it made me sleep walk and have weird dreams. I told the pharmacist that I never wanted this brand again and threw away most of my script.
image of drug pills surrounding a glass of water symbolizing drug consumption

Patient Q&A Section about carisoprodol

These questions and answers are submitted by anonymous patients, and have not been verified by our internal team.

Is carisoprodol a narcotic?

"Carisoprodol is not an opioid.

No, Soma (carisoprodol) is not a narcotic. People often use the word "narcotic" to describe all controlled substances, but a narcotic is actually a specific type of opioid pain reliever. Carisoprodol is not an opioid."

Answered by AI

Is carisoprodol a painkiller?

"6 days ago"

Answered by AI

Does carisoprodol 350 mg make you sleepy?

"Carisoprodol can make you feel drowsy and lightheaded. Do not drive or operate heavy machinery until you know how this medication affects you. Carisoprodol can be addictive and may lead to dependence."

Answered by AI

What is carisoprodol used for?

"This medicine is used to relax muscles and relieve discomfort caused by acute, painful muscle or bone conditions. However, it is not a replacement for rest, exercise, physical therapy, or other treatments that your doctor may recommend for your medical condition."

Answered by AI

Clinical Trials for Carisoprodol

Image of AltaSciences, Inc in Cypress, United States.

SBS-147 Safety Study

18 - 55
All Sexes
Cypress, CA

This study is part of the HEAL Initiative supported by the NIH. The purpose of this study is to learn how safe the study drug, SBS-147, is and how people's bodies respond to and process it. Researchers will also look for any side effects that may occur when taking SBS-147. Some participants will receive SBS-147, and others will receive a placebo, which looks the same but does not contain any medicine. This helps researchers fairly compare results. The study includes two parts: Single-Dose Group, where Participants receive SBS-147 or placebo one time. Multiple-Dose Group, where Participants receive SBS-147 or placebo once or twice daily for 7 days.

Phase 1
Waitlist Available

AltaSciences, Inc

Jeff Reich, MD

Sparian Biosciences, Inc

Image of Walter Reed National Military Medical Center in Bethesda, United States.

Corticosteroid Injections for Osteoarthritis

18+
All Sexes
Bethesda, MD

The goal of this clinical trial is to find out which type of steroid medicine, when added to a standard pain-control injection during total knee replacement surgery, works best at reducing pain, limiting opioid use, and improving recovery in adults undergoing surgery for severe knee arthritis or injury. The main questions it aims to answer are: Does adding a steroid to the injection improve pain control and reduce opioid use after surgery? Is the newer extended-release steroid (Zilretta) more effective and safer-especially for patients with diabetes-than the traditional steroid (methylprednisolone)? Researchers will compare: Standard pain-control injection alone Standard injection plus methylprednisolone Standard injection plus Zilretta to see which option provides better pain relief, less opioid use, and improved knee function. (Patients with diabetes or prediabetes will only be in the standard injection or Zilretta groups so researchers can study whether Zilretta is safer for blood sugar control.) Participants will: Be randomly assigned to one of the study groups during their total knee replacement surgery Receive the assigned pain-control injection around the knee joint Be followed after surgery to measure: Pain levels Opioid pain medication use Knee movement (range of motion) Whether another procedure (such as manipulation under anesthesia) is needed if the knee becomes too stiff Patient-reported outcome surveys about pain and function

Phase 2 & 3
Waitlist Available

Walter Reed National Military Medical Center

John P Cody, MD

Image of Lethbridge-Layton-Mackay Rehabilitation Center of CIUSSS West-Central Montreal (Mackay site) in Montreal, Canada.

Community-Based Activity Program for Physical Disabilities

12 - 18
All Sexes
Montreal, Canada

Participation in community-based activities is essential to the health and well-being of youth with physical disabilities; yet, it is extremely restricted. Emerging treatment approaches aimed at improving participation have shifted from focusing only on impaired body functions towards the performance of functional meaningful activities within the youth's natural environment. Investigators' initial results from studies in Quebec show that targeting intervention at the activity/participation level can result in improvement of impaired body functions (e.g., balance, attention, anxiety) - important components to address in rehabilitation. Investigators' team aims to continue studying the impact of participation by launching a larger more rigorous study. Investigators have partnered with major organizations providing rehabilitation services for youth as well as key community-based stakeholders including youth, clinicians, and managers, and together investigators plan to further examine whether engaging in an 8-week community-based activity individually chosen by the youth (e.g., sledge hockey, drawing, playing a musical instrument) can lead to a significant improvement in three key body functions: motor, behavioral and emotional. One hundred and fifty youth with physical disabilities living in Quebec and Ontario will participate and engage in an activity of choice. Changes in their body functions (e.g., movement, attention, mood) will be measured multiple times before, during and after engagement in the chosen activity. Findings of this study can guide clinicians, families and policy-makers to select effective approaches that not only promote participation but also facilitate additional motor and mental benefits from a single intervention. Such 'real-world' treatment approaches involving activities of choice can also increase motivation, compliance and reduce burden on the healthcare system and on the youth and families.

Waitlist Available
Has No Placebo

Lethbridge-Layton-Mackay Rehabilitation Center of CIUSSS West-Central Montreal (Mackay site)

Dana Anaby, PhD